4.8 Article

Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection

期刊

JOURNAL OF CONTROLLED RELEASE
卷 330, 期 -, 页码 1004-1015

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2020.11.008

关键词

Block copolymer; Chemotherapy; Esters; Polymeric micelles; Nanoparticles; Prodrugs

向作者/读者索取更多资源

The use of PEG-b-PLA and PEG-b-PCL nano-assemblies can enhance the water solubility of anticancer drugs, have lower toxicity compared to traditional organic solvents or solubilizers, and the prodrugs combined in the nano-assemblies significantly enhance the anticancer efficacy.
Poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-b-PLA) and poly(ethylene glycol)-block-poly(epsilon-caprolactone) (PEG-b-PCL) form nano-assemblies, including micelles and nanoparticles, that increase the water solubility of anticancer drugs for injection. PEG-b-PLA and PEG-b-PCL are less toxic than commonly used organic solvents or solubilizers for injection, such as Cremophor EL (R) in Taxol (R). Formulating paclitaxel in PEG-b-PLA micelles, as Genexol-PM (R), permits dose escalation over Taxol (R), enhancing antitumor efficacy in breast, lung and ovarian cancers. To expand the repertoire of anticancer drugs for injection, acyl and oligo(lactic acid) ester pmdrugs have been synthesized for PEG-b-PLA and PEG-b-PCL nano-assemblies, compatibility, and novel nanomedicines for injection. Notably, acyl and oligo(lactic acid) taxane prodrugs delivered by PEG-b-PLA and PEG-b-PCL nano-assemblies display heightened plasma exposure, reduction in biodistribution into major organs and enhanced tumor exposure in murine tumor models, versus parent anticancer drugs in conventional formulations. As a result, acyl and oligo(lactic acid) ester prodrugs are less toxic and induce durable antitumor responses. In summary, acyl and oligo(lactic acid) ester prodrugs widen the range of anticancer drugs that can be tested safely and effectively by using PEG-b-PLA and PEG-b-PCL nano-assemblies, and they display superior anticancer efficacy over parent anticancer drugs, which are often approved products. Oligo(lactic acid) ester taxane prodrugs are in pre-clinical development as novel drug combinations and immunotherapy combinations for cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Oligo(Lactic Acid)8-Rapamycin Prodrug-Loaded Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Micelles for Injection

Yu Tong Tam, Lauren Repp, Zhi-Xiong Ma, John B. Feltenberger, Glen S. Kwon

PHARMACEUTICAL RESEARCH (2019)

Article Engineering, Biomedical

HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours

Libor Kostka, Lenka Kotrchova, Vladimir Subr, Alena Libanska, Carolina A. Ferreira, Iva Malatova, Hye Jin Lee, Todd E. Barnhart, Jonathan W. Engle, Weibo Cai, Milada Sirova, Tomas Etrych

BIOMATERIALS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and characterization of CD54-targeted immunoPET imaging in solid tumors

Weijun Wei, Dawei Jiang, Hye Jin Lee, Miao Li, Christopher J. Kutyreff, Jonathan W. Engle, Jianjun Liu, Weibo Cai

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Review Chemistry, Multidisciplinary

Cell-Based Delivery Systems: Emerging Carriers for Immunotherapy

Zhaoting Li, Yixin Wang, Yingyue Ding, Lauren Repp, Glen S. Kwon, Quanyin Hu

Summary: Immunotherapy plays a crucial role in treating diseases, but its application is hindered by limited response rates and systemic side effects. Using natural cells as carriers can reduce immunogenicity and toxicity, while controlling their spatiotemporal distribution can enhance treatment efficacy and minimize side effects.

ADVANCED FUNCTIONAL MATERIALS (2021)

Review Nanoscience & Nanotechnology

Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS-CoV-2 testing development

Jianxin Wang, Adam J. Drelich, Caroline M. Hopkins, Sandro Mecozzi, Lingjun Li, Glen Kwon, Seungpyo Hong

Summary: In the midst of the COVID-19 pandemic, virus diagnostics have become crucial, with gold nanoparticle (AuNP) applications showing great potential in viral detection. Designing AuNP-based SARS-CoV-2 testing requires consideration of multiple factors, with the development of effective AuNP testing methods being critical for the future.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2022)

Article Chemistry, Multidisciplinary

Oligo(Lactic Acid)(8)-Docetaxel Prodrug-Loaded PEG-b-PLA Micelles for Prostate Cancer

Lauren Repp, Christopher J. Unterberger, Zhengqing Ye, John B. Feltenberger, Steven M. Swanson, Paul C. Marker, Glen S. Kwon

Summary: This study aimed to improve the stability of micelles by synthesizing an ester prodrug, successfully loading it within the micelle, solubilizing it in aqueous media, and delaying drug release. The prodrug rapidly converted to the parent drug post-release, showing efficacy and reduced toxicity compared to the traditional drug in a preclinical mouse model of prostate cancer.

NANOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer

Hye Jin Lee, Metti K. Gari, David R. Inman, Zachary T. Rosenkrans, Brian M. Burkel, Aeli P. Olson, Jonathan W. Engle, Reinier Hernandez, Suzanne M. Ponik, Glen S. Kwon

Summary: The study demonstrates that PEGylated FUD peptide has improved tumor exposure in a murine breast cancer model compared to non-PEGylated FUD. PEG-FUD maintains nanomolar binding affinity for FN in vitro and stability for up to 48 hours, showing potential as a therapeutic and imaging agent for breast cancer.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying

Morteza Rasoulianboroujeni, Lauren Repp, Hye Jin Lee, Glen S. Kwon

Summary: A new method named PEG-assist is introduced for the production of drug-loaded polymeric micelles. The method utilizes PEG as a solvent and shows significant improvement in the encapsulation efficiency of drugs in the micelles. It is a promising approach for large scale production due to its simplicity, cost-effectiveness, and efficiency.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models

Libor Kostka, Lenka Kotrchova, Eva Randarova, Carolina A. Ferreira, Iva Malatova, Hye Jin Lee, Aeli P. Olson, Jonathan W. Engle, Marek Kovar, Weibo Cai, Milada Sirova, Tomas Etrych

Summary: nanomedicines are being developed as an improved therapeutic option with reduced side effects, and this study introduces tailored nanosystems for the treatment of solid tumors or hematological malignancies. The relationship between the structure of the nanosystem and its distribution in the body was evaluated through independent assessments of the polymer carrier and drug pharmacokinetics. The results showed enhanced tumor accumulation of the polymer carriers in mice with solid tumors, as well as significant accumulation of doxorubicin bound to the polymer carriers in specific tumor types.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Pharmacology & Pharmacy

Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)8-Paclitaxel Prodrug Loaded Polymeric Micelles

Lauren Repp, Sarah L. Skoczen, Morteza Rasoulianboroujeni, Stephan T. Stern, Glen S. Kwon

Summary: PTX is a commonly used chemotherapy drug for treating various solid tumors. o(LA)(8)-PTX prodrug-loaded PEG-b-PLA micelles have higher loading, slower release, and greater antitumor efficacy compared to PTX-loaded PEG-b-PLA micelles. This study investigates the plasma stability and pharmacokinetics of o(LA)(8)-PTX-loaded PEG-b-PLA micelles in rats. The prodrug is metabolized into o(LA)(1)-PTX and PTX in rat plasma, while in human plasma, it is metabolized into o(LA)(2)-PTX, o(LA)(1)-PTX, and PTX. The abundance of metabolites in rat plasma after IV injection follows the order: o(LA)(1)-PTX > o(LA)(2)-PTX > o(LA)(4)-PTX > o(LA)(6)-PTX. Bile metabolite profiles are similar to plasma metabolite profiles. Compared to Abraxane, plasma exposure to PTX is 100 times higher for Abraxane, and plasma exposure to o(LA)(1)-PTX is five times higher, indicating enhanced antitumor efficacy.

AAPS JOURNAL (2023)

Article Pharmacology & Pharmacy

ImmunoPET Imaging of TIM-3 in Murine Melanoma Models

Weijun Wei, Dawei Jiang, Hye Jin Lee, Jonathan W. Engle, Hisaya Akiba, Jianjun Liu, Weibo Cai

ADVANCED THERAPEUTICS (2020)

Review Chemistry, Multidisciplinary

Polymer mechanochemistry in drug delivery: From controlled release to precise activation

Zhiyuan Shi, Yong Hu, Xin Li

Summary: Controlled drug delivery systems that can respond to mechanical force offer a unique solution for on-demand drug activation and release. Among various mechanical stimuli, ultrasound (US) has advantages in achieving spatiotemporally controlled drug release. Traditional US-triggered drug release relies on heat-induced phase transitions or chemical transformations, while the cutting-edge approach of Sonopharmacology leverages polymer mechanochemistry. The remaining challenges and potential future directions in this field are also discussed.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis

Lijie Zheng, Yuanzheng Chen, Xun Gu, Yingying Li, Hanqing Zhao, Wenjun Shao, Tao Ma, Chuanbin Wu, Qingqing Wang

Summary: In this study, a novel dosage form consisting of dissolving microneedles and an adhesive transdermal patch was developed for the treatment of rheumatoid arthritis. In vitro and in vivo experiments demonstrated that the combination of drugs delivered by this dosage form effectively reduced joint inflammation and damage.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides

Kyungjik Yang, Hwa Seung Han, Seung Hwan An, Kyung Hoon Park, Keonwook Nam, Shinha Hwang, Yuyeon Lee, Sung Yeon Cho, Taehyung Kim, Deokyeong Choe, Sang Won Kim, Wonkyu Yu, Hyunah Lee, Jiyong Park, Sangguan You, Dong- Gyu Jo, Ki Young Choi, Young Hoon Roh, Jae Hyung Park

Summary: This study developed CP-loaded CS microcapsules to enhance the oral bioavailability of CP through controlled gastrointestinal delivery. The optimized microcapsules exhibited desirable physicochemical properties, showed anti-photoaging effects via antioxidant activity, and achieved controlled release in the gastrointestinal tract. This research provides a simple and economical approach for enhancing the oral bioavailability of CP for customized bioactive compound administration.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema

Huiyang Li, Shuo Liu, Wenjin Dai, Bingmei Yao, Yong Zhou, Sujia Si, Hairong Yu, Riguang Zhao, Fang Jin, Liqun Jiang

Summary: Changes in bodily fluid pressures are crucial in diseases like high-altitude pulmonary edema (HAPE). Researchers have developed hydrostatic pressure-sensitive multivesicular liposomes (PSMVLs) that can release drugs in response to pressure changes, with potential applications in HAPE treatment. Animal experiments showed that this system provides better protection for lung tissues and respiratory function, reducing the occurrence of pulmonary edema.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia

Qian Hu, Hongbing Lan, Yinmei Tian, Xiaonan Li, Mengmeng Wang, Jiao Zhang, Yulin Yu, Wei Chen, Li Kong, Yuanyuan Guo, Zhiping Zhang

Summary: Coacervate droplets formed through liquid-liquid phase separation have potential as delivery vesicles for therapeutics. However, their lack of physiological stability and membranes are challenges. In this study, polylysine-polynucleotide complex coacervate droplets with favorable stability were formulated to concentrate molecules and nanoparticles. Phospholipid membranes were further coated on the droplets to create coacervate-based artificial protocells (ArtPC) with membrane-like structures. These biofunctional ArtPC effectively reduced blood uric acid levels and prevented renal injuries.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer

Xiaowei Wang, Hongwei Lu, Fang Luo, Dan Wang, Apeng Wang, Xuelei Wang, Wenkai Feng, Xiaobo Wang, Jiayi Su, Mingliang Liu, Guimin Xia

Summary: Four novel lipid-like GEM diesters were synthesized and encapsulated into liposomes to improve the antitumor efficacy of Gemcitabine. The liposomes loaded with dimyristoyl GEM (LipodmGEM) showed enhanced cellular uptake, improved inhibition of cell migration, and a greatly extended half-life compared to free Gemcitabine. LipodmGEM successfully enriched the drug in the tumor and exhibited excellent anticancer efficacy in vivo with negligible systemic toxicity.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment

Pengyu Li, Jieyi Pan, Yating Dong, Yingying Sun, Yalong Wang, Kang Liao, Yili Chen, Xin Deng, Shihui Yu, Haiyan Hu

Summary: Chronic pulmonary infection caused by Pseudomonas aeruginosa is a serious public health problem with high mortality rates. In this study, infection-microenvironment responsive nanoparticles were developed to eradicate biofilms and inhibit virulence. These nanoparticles showed promising results in treating chronic pulmonary infections.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Yajing Sun, Ze Lu, John A. Taylor, Jessie L. S. Au

Summary: A recent development in cancer chemotherapy is the use of cytotoxics to induce tumor-specific immune response through immunogenic cell death (ICD). This study describes a method that utilizes immunostaining and machine-learning to identify cells with ecto-CRT in intact 3-dimensional tissues. The method was successfully applied to study drug-induced ICD in human bladder cancer.

JOURNAL OF CONTROLLED RELEASE (2024)

Review Chemistry, Multidisciplinary

Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation

Rafat Ali, Shantanu Sen, Rohil Hameed, Aamir Nazir, Sandeep Verma

Summary: This review provides a focused overview of emerging strategies for delivering gasotransmitters in a controlled and sustained manner to reestablish neurophysiological homeostasis.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Multifunctional hydrogel for synergistic reoxygenation and chemo/ photothermal therapy in metastatic breast cancer recurrence and wound infection

Jing Chen, Xinyi Zhang, Jinshen Zhang, Zhaoxia Wang, Guilan Zhu, Ming Geng, Jinmiao Zhu, Yajun Chen, Wei Wang, Youcui Xu

Summary: In this study, a multifunctional responsive hydrogel system was developed for synergistic reoxygenation and chemo/photothermal therapy. The hydrogel system showed both therapeutic effects against metastatic breast cancer and wound infection, making it a promising strategy for treating and preventing tumor recurrence and associated wound infection.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: Inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation

Baoshan Huang, Na Zhang, Xinying Qiu, Rui Zeng, Shuimiao Wang, Mengxia Hua, Qing Li, Kaihui Nan, Sen Lin

Summary: This study revealed that robust ROS can oxidize mitochondrial DNA (ox-mtDNA) and cause its release into the cytosol, resulting in the activation of NLRP3 inflammasome. By using the mitochondria-targeted antioxidant SkQ1 and a novel mitochondria-targeted nanoparticle (SkQ1 NP), it was found that mitochondrial ROS scavenging could in situ inhibit DED-induced mtDNA oxidation and suppress NLRP3-mediated inflammation.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction

Wenqi Liu, Cheng Hu, Linyu Long, Shuyi He, Wen Zhang, Zhicun Wang, Li Yang, Yunbing Wang

Summary: Myocardial infarction is the leading cause of cardiovascular mortality, and current treatment methods have limitations. This study developed a smart carrier that can release different therapeutic substances for different pathological processes, effectively improving cardiac function, promoting cardiac repair, and preventing ventricular remodeling.

JOURNAL OF CONTROLLED RELEASE (2024)